- Home
- SAVA vs STRW Comparison
SAVA vs STRW Comparison
Compare SAVA & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- STRW
- Stock Information
- Founded
- SAVA 1998
- STRW 2015
- Country
- SAVA United States
- STRW United States
- Employees
- SAVA N/A
- STRW N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- STRW Real Estate Investment Trusts
- Sector
- SAVA Health Care
- STRW Real Estate
- Exchange
- SAVA Nasdaq
- STRW Nasdaq
- Market Cap
- SAVA 113.8M
- STRW 119.6M
- IPO Year
- SAVA N/A
- STRW N/A
- Fundamental
- Price
- SAVA $2.55
- STRW $11.46
- Analyst Decision
- SAVA Buy
- STRW Strong Buy
- Analyst Count
- SAVA 3
- STRW 4
- Target Price
- SAVA $111.50
- STRW $13.17
- AVG Volume (30 Days)
- SAVA 1.3M
- STRW 50.8K
- Earning Date
- SAVA 03-07-2025
- STRW 03-18-2025
- Dividend Yield
- SAVA N/A
- STRW 4.54%
- EPS Growth
- SAVA N/A
- STRW 23.40
- EPS
- SAVA N/A
- STRW 0.51
- Revenue
- SAVA N/A
- STRW $112,050,000.00
- Revenue This Year
- SAVA N/A
- STRW N/A
- Revenue Next Year
- SAVA N/A
- STRW $10.79
- P/E Ratio
- SAVA N/A
- STRW $22.52
- Revenue Growth
- SAVA N/A
- STRW 14.46
- 52 Week Low
- SAVA $2.23
- STRW $6.56
- 52 Week High
- SAVA $42.20
- STRW $12.90
- Technical
- Relative Strength Index (RSI)
- SAVA 41.47
- STRW 51.37
- Support Level
- SAVA $2.25
- STRW $11.43
- Resistance Level
- SAVA $2.36
- STRW $11.78
- Average True Range (ATR)
- SAVA 0.14
- STRW 0.41
- MACD
- SAVA 0.17
- STRW -0.00
- Stochastic Oscillator
- SAVA 50.85
- STRW 48.57
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
About STRW Strawberry Fields REIT Inc.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.